It has been proven that TGF-β by itself can promote invasiveness in cancer, but in some cases, like in breast cancer cells, it has been shown to collaborate between canonical TGF-β/SMAD3 signaling and the EGF/EGFR pathway to facilitate cancerous migration and invasive abilities [43]. Here, TGFB1 is linked to breast carcinoma.